Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients

被引：28
|
作者：
Du, J.
Zhang, A. [1 ]
Wang, L. [1 ]
Xuan, J. [1 ]
Yu, L. [1 ]
Che, R. [1 ]
Li, X. [1 ]
Gu, N. [3 ]
Lin, Z. [3 ]
Feng, G. [3 ]
Xing, Q. [1 ]
He, L. [1 ,2 ]
机构：
[1] Chinese Acad Sci, Inst Nutr Sci, SIBS, Shanghai 200031, Peoples R China
[2] Shanghai Jiao Tong Univ, Bio X Ctr, NHGG, Shanghai 200030, Peoples R China
[3] Shanghai Inst Mental Hlth, Shanghai, Peoples R China
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2010年 / 24卷 / 07期
基金：
中国国家自然科学基金;
关键词：
9-hydroxyrisperidone; clinical response; CYP3A4; risperidone; schizophrenia; ANTIPSYCHOTIC-DRUGS; METABOLISM; RELAPSE; CYP2D6; PREVENTION; POOR; 2D6;
D O I：
10.1177/0269881109104932
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In this study, we examined the relationships between plasma concentrations of risperidone and 9-hydroxyrisperidone and polymorphisms of CYP3A4. All 130 schizophrenia patients (45 men, 85 women, age 15-60 years) who met DSM-IV criteria were given risperidone for 8 weeks. Clinical efficacy was determined using the Positive and Negative Syndrome Scale (PANSS). CYP3A4*1G was found to be associated with the change in total PANSS scores (Kruskal-Wallis test, P = 0.021), which was not significant on adjusting for multiple testing. Our study has, for the first time, conducted a genetic association study of the CYP3A4 gene with risperidone response. Further studies on larger groups and on the effects of the longer term risperidone treatment are needed to confirm these results.
引用
收藏
页码：1115 / 1120
页数：6
相关论文
共 50 条
  • [41] Plasma Venetoclax Concentrations in Patients with Acute Myeloid Leukemia Treated with CYP3A4 Inhibitors
    Otsuki, Ayaka
    Kumondai, Masaki
    Kobayashi, Daisuke
    Kikuchi, Masafumi
    Ueki, Yugo
    Sato, Yuji
    Hayashi, Nagomi
    Yagi, Ayaka
    Onishi, Yasushi
    Onodera, Koichi
    Ichikawa, Satoshi
    Fukuhara, Noriko
    Yokoyama, Hisayuki
    Maekawa, Masamitsu
    Mano, Nariyasu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2024, 144 (07): : 775 - 779
  • [42] Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder
    Spina, Edoardo
    D'Arrigo, Concetta
    Migliardi, Gaetana
    Santoro, Vincenza
    Muscatello, Maria Rosaria
    Mico, Umberto
    D'Amico, Giuseppina
    Perucca, Emilio
    THERAPEUTIC DRUG MONITORING, 2006, 28 (05) : 599 - 602
  • [43] Risperidone plasma concentrations are associated with hyperprolactinemia in autism spectrum disorder children: The impact of CYP2D6 polymorphisms
    Chamnanphon, Monpat
    Vanwong, Natchaya
    Prommas, Santirhat
    Koomdee, Napatrupron
    Sukprasong, Rattanaporn
    Rachanakul, Jiratha
    Nuntharadthanaphong, Nutthan
    Hongkaew, Yaowaluck
    John, Shobana
    Ngamsamut, Nattawat
    Nuntamool, Nopphadol
    Limsila, Penkhae
    Sukasem, Chonlaphat
    RESEARCH IN AUTISM SPECTRUM DISORDERS, 2022, 96
  • [44] Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes
    Yasui-Furukori, N
    Hidestrand, M
    Spina, E
    Facciolá, G
    Scordo, MG
    Tybring, G
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (10) : 1263 - 1268
  • [45] Impact of CYP3A4 polymorphisms on donepezil plasma levels and therapeutic outcome
    Scordo, M. G.
    Villa, L. M.
    Miglio, G.
    Lombardi, G.
    Dahl, M. L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S531 - S532
  • [46] Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extendedrelease paliperidone tablets in patients with schizophrenia
    Yang, Dong Suk
    Seong, Sook Jin
    Yoon, Young-Ran
    Lim, Mi-Sun
    Kwak, Kyung-Hwa
    Lee, Seung Jae
    JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (04) : 341 - 348
  • [47] Gender differences in the relationship between the risperidone metabolism and the plasma prolactin levels in psychiatric patients
    Suzuki, Yutaro
    Fukui, Naoki
    Watanabe, Junzo
    Ono, Shin
    Sugai, Takuro
    Tsuneyama, Nobuto
    Inoue, Yoshimasa
    Someya, Toshiyuki
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (07): : 1266 - 1268
  • [48] Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia
    Yasui-Furukori, Norio
    Saito, Manabu
    Nakagami, Taku
    Sugawara, Norio
    Sato, Yasushi
    Tsuchimine, Shoko
    Furukori, Hanako
    Kaneko, Sunao
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (03): : 537 - 540
  • [49] Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations
    Tiina Karonen
    Jouko Laitila
    Mikko Niemi
    Pertti J. Neuvonen
    Janne T. Backman
    European Journal of Clinical Pharmacology, 2012, 68 : 681 - 688
  • [50] Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
    Jinjun Lu
    Ye Yang
    Jian Lu
    Zuqing Wang
    Yiping He
    Yeliang Yan
    Kai Fu
    Wenjuan Jiang
    Yunqing Xu
    Renrong Wu
    Wenqing Liu
    Jingping Zhao
    BMC Psychiatry, 21
12345